Connect with us

Health

Lassa fever death reported in midwestern state, contact tracing begins

Published

on

Lassa fever death reported in midwestern state, contact tracing begins

A middle-aged Iowa resident has died from Lassa fever, according to an alert from the Iowa Department of Health & Human Services (HHS).

The person, whose name and age were not shared, had recently returned to the state after traveling to West Africa, the release stated.

The initial testing of the patient was performed on Monday at the Nebraska Public Health Laboratory on Monday, and the Centers for Disease Control and Prevention (CDC) is “working to confirm the diagnosis,” per Iowa HHS.

FAUCI SAYS WEST NILE VIRUS WAS A ‘HARROWING’ EXPERIENCE: ‘AFRAID I WOULD NEVER RECOVER’

“This is a difficult time for the family of this individual and I want to express our deepest condolences,” said Dr. Robert Kruse, state medical director of IOWA HHS, in the release. 

Advertisement

Lassa fever is a hemorrhagic viral infection spread by rats in West Africa. (iStock)

“I want to assure Iowans that the risk of transmission is incredibly low in our state. We continue to investigate and monitor this situation and are implementing the necessary public health protocols.”

The patient received care at the University of Iowa Health Care, which is working closely with Iowa HHS, the CDC and other local public health partners to assist with contact tracing and monitoring, per the release.

What is Lassa fever?

Lassa fever is a hemorrhagic viral infection spread by rats in West Africa, according to Edward Liu, M.D., chief of infectious diseases at Hackensack Meridian Jersey Shore University Medical Center.

The viral illness is transmitted by a certain type of rat called the “multimammate rat” or Mastomys natalensis (Mastomys), per the CDC.

Advertisement

DEADLY MARBURG VIRUS OUTBREAK IN RWANDA HAS HEALTH OFFICIALS ON HIGH ALERT

“This is a very rare disease,” Liu told Fox News Digital.  

“Public health will have to follow close contacts of the patient to make sure there are no subsequent cases of Lassa fever.”

Lassa testing

“Diagnostic testing can be done in a laboratory with a high level of biosafety and enhanced infection prevention and control precautions,” the CDC noted. (iStock)

People can catch the fever through contact with infected rats or their saliva, urine or droppings, the same source stated. 

“Lassa fever can also spread between people by close contact with bodily fluids,” Lui told Fox News Digital. 

Advertisement

“Casual contact is not sufficient to transmit Lassa fever.”

“Lassa usually is a mild disease, but in severe cases it can cause uncontrolled bleeding and shock.”

The CDC confirmed that Lassa fever is not spread through hugging, shaking hands or sitting near someone.

“People with Lassa fever are not contagious until after their symptoms begin,” the agency stated.

Hospital PPE

Not using proper personal protective equipment (PPE) or not properly sterilizing equipment in health care settings can cause the illness to spread. (iStock)

Below are some of the ways in which the virus can spread, as listed on the CDC’s website.

Advertisement
  • Touching contaminated objects
  • Eating food that has the virus
  • Getting the virus in open cuts or sores
  • Eating rodents
  • Breathing in air that has infected urine or droppings, which can occur when cleaning or sweeping
  • Not using proper personal protective equipment (PPE) or not properly sterilizing equipment in health care settings

Symptoms of infection

While about 80% of people experience only mild symptoms, it can be fatal in rare cases.

“Lassa is usually a mild disease, but in severe cases it can cause uncontrolled bleeding and shock,” Lui cautioned.

Those with mild illness may have a slight fever, fatigue, weakness and headache, according to the CDC.

      

In some cases, the fever can cause bleeding, breathing difficulties, vomiting, facial swelling, shock, and pain in the chest, back and abdomen.

Symptoms typically begin within one to three weeks after a person is infected.

Advertisement
Lassa pills

The antiviral drug Ribavirin has been shown to be effective in treating the infection, the CDC stated. (iStock)

Hearing loss is a known effect of Lassa fever, with about 30% of people experiencing some level of deafness, the CDC stated. In some cases, the hearing loss can be permanent.

Pregnant women face a high risk of miscarriage if they are infected.

Diagnosis and treatment

Anyone who has visited West Africa and is experiencing symptoms should seek medical attention.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

“Diagnostic testing can be done in a laboratory with a high level of biosafety and enhanced infection prevention and control precautions,” the CDC noted.

Advertisement
Sick woman

Supportive care — including rest, hydration and treatment of symptoms — is recommended for those with Lassa fever. (iStock)

The antiviral drug Ribavirin has been shown to be effective in treating the infection.

Supportive care — including rest, hydration and treatment of symptoms — is also recommended.

Preventing Lassa fever

The best way to prevent catching Lassa fever, according to the CDC, is to stay away from rats when visiting West Africa. 

It is also recommended to keep food in rat-proof containers, trap rats in and around homes, and avoid eating rats.

For more Health articles, visit www.foxnews.com/health

Advertisement

Health care personnel should wear protective clothing, sterilize equipment and follow other infection control protocols when caring for infected patients, the agency added.

Health

Hone Health: Facts About Prescription Non-GLP-1 Weight Loss | Woman's World

Published

on

Hone Health: Facts About Prescription Non-GLP-1 Weight Loss | Woman's World


Advertisement


Hone Health: Facts About Prescription Non-GLP-1 Weight Loss | Woman’s World



























Advertisement






Advertisement


Use left and right arrow keys to navigate between menu items.


Use escape to exit the menu.

Advertisement

Continue Reading

Health

Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error

Published

on

Clonazepam, popular anxiety-reducing drug, recalled nationwide for ‘possibly life-threatening’ error

The anxiety-reducing drug, Clonazepam, has been recalled after a potentially “life-threatening” label mix-up, the Food and Drug Administration (FDA) said. 

According to a release from the federal agency, Endo Inc. announced a voluntary recall of 16 lots of Clonazepam Orally Disintegrating Tablets.

The pharmaceutical company said the immediate recall came after it was discovered that 16 lots of the anxiety drug were mislabeled with the incorrect strength and National Drug Code (NDC) on them. The company said the labeling error was made by a third-party packager.

As a result, children and adults prescribed Clonazepam could face “life-threatening” side effects, the FDA warned.

‘I’M A PHARMACIST, AND I WOULDN’T TAKE THESE 3 VITAMIN SUPPLEMENTS’

Advertisement

The recalled products were distributed to pharmacies nationwide in cartons containing 60 tablets packed into 10 blister strips of six tablets. (FDA)

The mislabeling of the drug could result in “significant sedation, confusion, dizziness, diminished reflexes, ataxia, and hypotonia,” the FDA said.

“There is reasonable probability for significant, possibly life-threatening, respiratory depression especially for patients with concomitant pulmonary disease, patients who have prescribed dosing near maximal dosing, and patients also taking other medications that could cause additional respiratory depression,” the FDA said.

Endo Inc. noted that, as of Nov. 21, there have not been any reports of adverse effects from the product recall.

Back of package

The company said the labeling error was made by a third-party packager.  (FDA)

The following table, provided by the FDA, details the lots being added to the voluntary recall, including lot product description and NDC number:

Advertisement
Potential Product Description / NDC Number Lot #
Clonazepam ODT, USP (C-IV) 2mg / 49884-310-02 550176501
550176601
Clonazepam ODT, USP (C-IV) 0.125mg / 49884-306-02 550174101
Clonazepam ODT, USP (C-IV) 0.25mg / 49884-307-02 550142801
550142901
550143001
550143101
550143201
550143301
550143401
550147201
550147401
Clonazepam ODT, USP (C-IV) 1mg / 49884-309-02 550145201
550175901
550176001
550176201

Individuals with unused prescribed tablet cartons of Clonazepam Orally Disintegrating tablets bearing the above lot numbers have been advised to discontinue use of the product.

BREAST CANCER VACCINE UPDATE FROM CLEVELAND CLINIC: ‘A NEW ERA’

In the event that a patient inadvertently took an incorrect dose rather than the intended dose, they are advised to consult a physician, the FDA said.

Consumers with questions about the recall can contact Inmar Inc., the company handling the recalls, by telephone at 855-589- 1869 or by email at rxrecalls@inmar.com.

Advertisement
FDA sign outside headquarters.

Signage is seen outside the Food and Drug Administration (FDA) headquarters in White Oak, Maryland. (REUTERS/Andrew Kelly/File Photo)

Clonazepam tablets treat seizures and can also be used to treat panic disorder, according to the Cleveland Clinic.

“It works by helping your nervous system calm down,” the Cleveland Clinic said. “It belongs to a group of medications called benzodiazepines.”

Continue Reading

Health

These Tasty Food Swaps Make Weight Loss Easy—and You Won’t Feel Deprived!

Published

on

These Tasty Food Swaps Make Weight Loss Easy—and You Won’t Feel Deprived!


Advertisement


Healthy Food Swaps That Aid Weight Loss and Help You Feel Full  | Woman’s World




















Advertisement














Advertisement


Use left and right arrow keys to navigate between menu items.

Advertisement


Use escape to exit the menu.

Continue Reading
Advertisement

Trending